Revitalist Publishes Proprietary Diagnostic Tool After Receiving Certificate of Registration from The United States… Jan 27, 2022
atai Life Sciences Launches Invyxis to Accelerate Discovery of Next-Generation Mental Health Treatments Jan 27, 2022
Revitalist Provides Summary of 2021, Reporting Patient Visits of 5,000, a 128% Increase From 2020 Jan 20, 2022
How Significant Are Recent Changes To Psychedelics Access In Canada? ‘It Can’t Be Understated’ Says Numinus CEO Jan 12, 2022
PharmaTher Announces FDA Approval of Investigational New Drug (IND) Application for Ketamine to Treat ALS Jan 12, 2022
Institutional Review Board Grants Approval for Cybin-Sponsored Feasibility Study Using Kernel Flow Technology to Measure… Jan 11, 2022
